"Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma" by S. Martin-Algarra

Selected Works of Walter J. Urba, MD, PhD

Follow Contact

Article

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

Annals of Oncology (2016)

S. Martin-Algarra
J.B. Haanen
C. Horak
S. Bhatia
A. Ribas
W-J. Hwu
C.L. Slingluff
W.H. Sharfman
M. Callahan
F.S. Hodi
J.D. Wolchok
J. Luke
T.C. Young
A. Qureshi
W.J. Urba

Link

Disciplines

Medicine and Health Sciences,
Surgery and
Oncology

Publication Date

October 1, 2016

DOI

10.1093/annonc/mdw379.20

Citation Information

S. Martin-Algarra, J.B. Haanen, C. Horak, S. Bhatia, et al.. "Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma" Annals of Oncology Vol. 27 (2016)
Available at: http://works.bepress.com/walter-urba/256/